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Author’s reply
Danon disease is an X-linked myopathy that was ﬁrst reported
by Danon et al. in 1981 as a ‘‘ Lysosomal glycogen storage disease
with normal acid maltase’’ [1]. The disease is characterized by
three major symptoms, cardiomyopathy, muscle weakness,
and mild mental retardation, and has a wide spectrum of
clinical features. Although male patients usually develop severein a female patient. This is the ﬁrst report that demonstrated th
validity of a ﬂow cytometry method for intra-family search o
Danon disease within the affected family and successful screenin
of a presymptomatic case [2]. This result indicates that th
method is a useful screening technique for searching the cause o
cardiomyopathy of unknown etiology. However, a critical refer
ence was not cited in this study report [3]. This was simply cause
by an overlook that occurred between the diagnosis of th
proband (2008) and the ﬁnal acceptance of the manuscript b
the Journal of Cardiology; that is, after completion of the project, th
manuscript went through several review processes by multipl
journals and the error occurred during this process. We sincerel
apologize for our carelessness.
The purpose of this article is not to discuss the geneti
background of a case in which genetic abnormalities were no
identiﬁed by a standard genetic test in the mother of the child wit
the X-linked Danon disease or a case where identiﬁcation wa
challenging even with our ﬂow cytometry method. In addition, i
remains unknown whether females with mosaicism consistentl
show the phenotype of Danon disease. As suggested, a detaile
examination of the genotype of the mother is essential to elucidat
the pathology; however, this is beyond the scope of this projec
Nevertheless, it does not change the fact that this method is usefu
for diagnosing myopathy that has already developed or fo
diagnosing a presymptomatic heterozygous female with Dano
disease who has a deﬁnite chance of developing the symptom i
the future. This is the ﬁrst study that demonstrated the validit
of this method.
Although the mother was described to have ‘‘chimerism’
‘‘mosaicism’’ is the correct term as suggested and we have revise
it accordingly.
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